High Incidence of Discontinuations Due to Adverse Events in Patients Treated with Ceftaroline

Ceftaroline for meticillin-resistant Staphylococcus aureus bacteraemia: Case series and review of the literature

(2013) Hari M. Polenakovik et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Ceftaroline in the treatment of concomitant methicillin-resistant and daptomycin-non-susceptible Staphylococcus aureus infective endocarditis and osteomyelitis: case report

(2013) K. Jongsma et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Ceftaroline - a cause for neutropenia

(2013) R. H. Rimawi et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Addition of Ceftaroline to Daptomycin after Emergence of Daptomycin-Nonsusceptible Staphylococcus aureus during Therapy Improves Antibacterial Activity

(2012) Warren E. Rose et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Methicillin-resistant Staphylococcus aureus bacteraemia and endocarditis treated with ceftaroline salvage therapy

(2012) T. T. Ho et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The use of ceftaroline fosamil in methicillin-resistant Staphylococcus aureus endocarditis and deep-seated MRSA infections: a retrospective case series of 10 patients

(2012) Jennifer C. Lin et al.   JOURNAL OF INFECTION AND CHEMOTHERAPY

Integrated Analysis of CANVAS 1 and 2: Phase 3, Multicenter, Randomized, Double‐Blind Studies to Evaluate the Safety and Efficacy of Ceftaroline versus Vancomycin plus Aztreonam in Complicated Skin and Skin‐Structure Infection

(2010) G. Ralph Corey et al.   CLINICAL INFECTIOUS DISEASES

Integrated Analysis of FOCUS 1 and FOCUS 2: Randomized, Doubled‐Blinded, Multicenter Phase 3 Trials of the Efficacy and Safety of Ceftaroline Fosamil versus Ceftriaxone in Patients with Community‐Acquired Pneumonia

(2010) Thomas M. File et al.   CLINICAL INFECTIOUS DISEASES

Cephalosporin-Induced Leukopenia Following Rechallenge with Cefoxitin

(2008) Craig B Whitman et al.   ANNALS OF PHARMACOTHERAPY